Blood cleansing device removes pathogens Path Ex, a small business funded by the National Science Foundation (NSF), is developing a device to remove pathogens from blood. Path Ex’s device can selectively remove pathogens and treat drug-resistant bacteria and endotoxins from circulating...
You are here
Path Ex, Inc.
111 10th Ave S Ste 105Nashville, TN 37203-3806
# of Employees: 2
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: Yes
SBIR Phase II: Rapid Blood Cleansing Device to Combat InfectionAmount: $750,000.00
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project will be the development of a fluidic platform for selective bacterial and endotoxin removal f ...SBIRPhase II2018National Science Foundation
STTR Phase I: Rapid Blood Cleansing Device to Combat InfectionAmount: $225,000.00
The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to develop a dialysis-like platform for selective bacterial separation and removal from blo ...STTRPhase I2017National Science Foundation